Author/Authors :
Laurent Peyrin-Biroulet، نويسنده , , Pierre Desreumaux، نويسنده , , William J. Sandborn، نويسنده , , Jean-Frédéric Colombel، نويسنده ,
Abstract :
Summary
In the past few years, antagonists of tumour necrosis factor have resulted in unforetold therapeutic benefits in Crohnʹs disease, but the magnitude and duration of responses are variable. New agents are therefore needed. Their development has bene
